136 related articles for article (PubMed ID: 4609824)
1. Humoral Anti-Ehrlich carcinoma factor found in mice with tumor resistance acquired by intradermal lipopolysaccharide administration.
Yamazaki M; Ohkuma S; Mizuno D
Gan; 1974 Aug; 65(4):337-44. PubMed ID: 4609824
[No Abstract] [Full Text] [Related]
2. Effect of Proteus vulgaris lipopolysaccharide on resistance of mice inoculated with tumor cells sensitized to Ehrlich carcinoma transplantation.
Kato N; Ito S; Yamazaki M; Mizuno D
Gan; 1973 Apr; 64(2):111-20. PubMed ID: 4124878
[No Abstract] [Full Text] [Related]
3. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
Weiland E; Weiland F
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
[No Abstract] [Full Text] [Related]
4. Transplantability and antigenicity of two sublines of the TA3 tumor.
Sanford BH; Codington JF; Jeanloz RW; Palmer PD
J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
[No Abstract] [Full Text] [Related]
5. Antitumor effect of intracutaneous injection of bacterial lipopolysaccharide.
Mizuno D; Yoshioka O; Akamatu M; Kataoka T
Cancer Res; 1968 Aug; 28(8):1531-7. PubMed ID: 5673568
[No Abstract] [Full Text] [Related]
6. Induction of resistance against Ehrlich carcinoma by tumor cells sensitized with immunized rabbit serum.
Kato N; Ito S; Mizuno D
Gan; 1972 Apr; 63(2):173-9. PubMed ID: 5070236
[No Abstract] [Full Text] [Related]
7. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
Abe S; Yoshioka O; Masuko Y; Tsubouchi J; Kohno M; Nakajima H; Yamazaki M; Mizono D
Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591
[TBL] [Abstract][Full Text] [Related]
8. Effect of splenectomy on the regression of transplantable tumors.
Ferrer JF; Mihich E
Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442
[No Abstract] [Full Text] [Related]
9. A kinetic aspect of the antibody production against Ehrlich tumor cells in mice bearing Ehrlich solid tumor.
Kaneko Y; Nitta K; Umezawa H
Gan; 1975 Oct; 66(5):573-5. PubMed ID: 1220993
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Ehrlich ascites tumors in mice by minute virus of mice.
Guetta E; Graziani Y; Tal J
J Natl Cancer Inst; 1986 Jun; 76(6):1177-80. PubMed ID: 3458953
[TBL] [Abstract][Full Text] [Related]
11. [Preventive immunization and immunotherapy of Ehrlich carcinoma and Crocker sarcoma in mice].
Zatula DG
Biull Eksp Biol Med; 1969; 67(1):62-4. PubMed ID: 5404408
[No Abstract] [Full Text] [Related]
12. Isolation of Proteus vulgaris MC-63 from carcinoma 63 and its antitumor effect on Crocker sarcoma 180 and Ehrlich carcinoma.
Toda H
Sci Rep Res Inst Tohoku Univ Med; 1970 Jul; 17(1):71-5. PubMed ID: 4948325
[No Abstract] [Full Text] [Related]
13. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
Valguarnera G
Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
[No Abstract] [Full Text] [Related]
14. In vitro measurement of cytotoxic antibodies in mouse-immune sera against mouse ascites tumor cells.
Eng CP; Tolbert WR; Harnaha JB; Concannon JP
Can J Microbiol; 1974 Dec; 20(12):1681-8. PubMed ID: 4479949
[No Abstract] [Full Text] [Related]
15. Two-step mechanism of macrophage-mediated tumor lysis in vitro.
Yamazaki M; Shinoda H; Suzuki Y; Mizuno D
Gan; 1976 Oct; 67(5):741-5. PubMed ID: 797628
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
Janik P; Dabrowski M; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
[No Abstract] [Full Text] [Related]
17. Tumor-specific transplantation resistance in mice after treatment of initial tumors with Streptococcus thermophilus.
Kaklij GS; Kelkar SM
Microbiol Immunol; 1996; 40(1):55-8. PubMed ID: 8871529
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action and cytotoxic, biochemical and histochemical effects of antibodies and complement on neoplastic cells and experimental malignant neoplasms].
Valguarnera G
Ann Sclavo; 1974; 16(4):367-85. PubMed ID: 4441141
[No Abstract] [Full Text] [Related]
19. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
[TBL] [Abstract][Full Text] [Related]
20. [Effect of different polysaccharides on the growth behavior of Ehrlich-ascites tumors].
Osswald H
Arzneimittelforschung; 1968 Dec; 18(12):1495-8. PubMed ID: 5756242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
